Target intelligence / Profile preview

Kinesin family member 23 pseudogene

Molecular classification
Pseudogene, Non-coding RNA (when transcribed)
01

Overview

Kinesin family member 23 pseudogene (ENSG00000271660) is a genomic locus similar in sequence to the protein-coding KIF23 gene but lacks the necessary sequence features for functional protein expression, such as regulatory elements or intact open reading frames[3]. Pseudogenes typically arise due to gene duplication or retrotransposition events followed by disabling mutations, such as frameshifts or premature stop codons[3]. While most pseudogenes are considered *non-functional "junk DNA"*[1], some can have regulatory roles, including acting as microRNA sponges or generating small interfering RNAs, although such functions are rare and not established for this particular pseudogene[3]. There is no evidence that ENSG00000271660 acts as a therapeutic target or that drugs interact with it; therefore, it is not considered a receptor, enzyme, transporter, or other relevant drug target class. ENSG00000271660 is not a valid drug target and is not involved in canonical receptor or enzyme activities. It is a pseudogene, with no abbreviation in use and minimal evidence for biological or disease relevance. Pseudogenes are generally not considered for therapeutic targeting unless specific regulatory functions are experimentally validated[3].

Other names
KIF23 pseudogenePseudogene of KIF23
02

Biological functions

Other (pseudogenes may serve regulatory roles such as microRNA decoys or sources of siRNA in rare instances, but typically lack protein-coding function)
03

Disease associations

Other (there are rare cases where pseudogenes may have regulatory effects implicated in diseases, but there is no evidence for this specific pseudogene)

Beyond the preview

Go deeper on Kinesin family member 23 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin family member 23 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call